0.7203
price up icon7.12%   0.0378
 
loading

Biofrontera Inc (BFRI) 最新ニュース

pulisher
May 08, 2025

Biofrontera (BFRI) to Release Earnings on Thursday - Defense World

May 08, 2025
pulisher
May 06, 2025

Dermatology Leader Biofrontera Announces First Quarter 2025 Earnings Date: Key Details Inside - Stock Titan

May 06, 2025
pulisher
May 06, 2025

Biofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025 - ACCESS Newswire

May 06, 2025
pulisher
May 02, 2025

Biofrontera and Almirall Launch the Hats On Challenge to Raise Awareness and Support for Actinic Keratosis - GlobeNewswire

May 02, 2025
pulisher
May 01, 2025

Major Skin Cancer Prevention Campaign Launches as 58M Americans Face Actinic Keratosis Risk - Stock Titan

May 01, 2025
pulisher
Apr 29, 2025

Biofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business Update - ADVFN

Apr 29, 2025
pulisher
Apr 28, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 28, 2025
pulisher
Apr 16, 2025

Biofrontera Inc. (NASDAQ:BFRI) Sees Large Decrease in Short Interest - Defense World

Apr 16, 2025
pulisher
Apr 13, 2025

Biofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma (sBCC) - Revista ADVFN

Apr 13, 2025
pulisher
Apr 07, 2025

Biofrontera Inc. Reports Record Sales and Strategic Advances - MSN

Apr 07, 2025
pulisher
Apr 01, 2025

Virtu Financial LLC Invests $48,000 in Biofrontera Inc. (NASDAQ:BFRI) - The AM Reporter

Apr 01, 2025
pulisher
Mar 25, 2025

Benchmark maintains Buy rating on Biofrontera stock, target at $7 By Investing.com - Investing.com Australia

Mar 25, 2025
pulisher
Mar 25, 2025

Biofrontera Inc. (NASDAQ:BFRI) Q4 2024 Earnings Call Transcript - MSN

Mar 25, 2025
pulisher
Mar 25, 2025

Benchmark maintains Buy rating on Biofrontera stock, target at $7 - Investing.com India

Mar 25, 2025
pulisher
Mar 22, 2025

Biofrontera outlines 2025 growth strategies with new FDA approvals and clinical progress - MSN

Mar 22, 2025
pulisher
Mar 22, 2025

Biofrontera Full Year 2024 Earnings: Misses Expectations - Yahoo Finance

Mar 22, 2025
pulisher
Mar 22, 2025

Biofrontera Inc (BFRI) Q4 2024 Earnings Call Highlights: Record Revenue Growth Amidst Financial ... By GuruFocus - Investing.com Canada

Mar 22, 2025
pulisher
Mar 22, 2025

Biofrontera Inc. Q4 2024 Earnings: A Deep Dive into the Numbers - AInvest

Mar 22, 2025
pulisher
Mar 21, 2025

Biofrontera Inc. Reports Record Revenue Growth in 2024 - TipRanks

Mar 21, 2025
pulisher
Mar 21, 2025

Biofrontera Inc. reports Q4 EPS (19c) vs $1.65 last year - TipRanks

Mar 21, 2025
pulisher
Mar 21, 2025

Earnings call transcript: Biofrontera Q4 2024 sees revenue growth and strategic shifts - Investing.com India

Mar 21, 2025
pulisher
Mar 21, 2025

Biofrontera Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 21, 2025
pulisher
Mar 21, 2025

Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update - TradingView

Mar 21, 2025
pulisher
Mar 21, 2025

Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update - GlobeNewswire Inc.

Mar 21, 2025
pulisher
Mar 21, 2025

Earnings Scheduled For March 21, 2025 - Benzinga

Mar 21, 2025
pulisher
Mar 20, 2025

Biofrontera Inc. (BFRI) reports earnings - Quartz

Mar 20, 2025
pulisher
Mar 20, 2025

Biofrontera Inc. SEC 10-K Report - TradingView

Mar 20, 2025
pulisher
Mar 18, 2025

Biofrontera Completes Patient Enrollment for Phase 3 Trial of Ameluz in Actinic Keratoses - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

Biofrontera completes patient enrollment in Phase 3 study of Ameluz - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

Biofrontera Inc. Announces Completion of Patient Enrollment - GlobeNewswire

Mar 18, 2025
pulisher
Mar 18, 2025

Major Milestone: Biofrontera's Skin Cancer Treatment Targets New Body Areas in Phase 3 Trial - StockTitan

Mar 18, 2025
pulisher
Mar 18, 2025

3 Reasons to Avoid KIND and 1 Stock to Buy Instead - The Globe and Mail

Mar 18, 2025
pulisher
Mar 18, 2025

Biofrontera Inc. Announces Completion of Patient Enrollment in Phase 3 Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Actinic Keratoses on the Extremities, Neck and Trunk - GlobeNewswire

Mar 18, 2025
pulisher
Mar 14, 2025

Biofrontera (BFRI) to Release Earnings on Friday - Defense World

Mar 14, 2025
pulisher
Mar 11, 2025

Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025 - GlobeNewswire

Mar 11, 2025
pulisher
Mar 11, 2025

BIOFRONTERA Earnings Preview: Recent $BFRI Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 11, 2025
pulisher
Mar 11, 2025

Dermatology Leader Biofrontera Sets Q4 Earnings Date: Key Growth Updates Expected - StockTitan

Mar 11, 2025
pulisher
Mar 06, 2025

Biofrontera (BFRI) Projected to Post Earnings on Thursday - Defense World

Mar 06, 2025
pulisher
Mar 03, 2025

Biofrontera Inc. (NASDAQ:BFRI) Short Interest Down 25.0% in February - Defense World

Mar 03, 2025
pulisher
Feb 27, 2025

Investors Aren't Entirely Convinced By Biofrontera Inc.'s (NASDAQ:BFRI) Revenues - Simply Wall St

Feb 27, 2025
pulisher
Feb 22, 2025

When Will Biofrontera Inc. (NASDAQ:BFRI) Turn A Profit? - Yahoo Finance

Feb 22, 2025
pulisher
Feb 22, 2025

Biofrontera (NASDAQ:BFRI) Trading Down 3.5% – What’s Next? - Defense World

Feb 22, 2025
pulisher
Feb 12, 2025

Constellation Brands: A Fallen Star or a Hidden Value Play? - The Globe and Mail

Feb 12, 2025
$30.98
price up icon 4.18%
$79.28
price down icon 0.04%
$8.77
price down icon 1.62%
$120.43
price up icon 4.08%
drug_manufacturers_specialty_generic RDY
$14.12
price up icon 1.29%
$307.23
price up icon 3.11%
大文字化:     |  ボリューム (24 時間):